Structural Formula For Cedfinir Monohydrate (Image 1)
Cefdinir Powder, For Suspension
Product Images NDC 0093-4136
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 0093-4136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 2)
This is a description of the medication Cefdinir for Oral Suspension USP in a concentration of 125 mg/5 mL. It is meant to be reconstituted with 50 L of water and will result in a 60 mL solution. The medication is packaged with an NDC code of 0093-4136-64 and manufactured by Sharewell Seone Ui. Any unused portion of the medication must be discarded.*
Image (Image 3)
This is a description of an oral suspension medication called Cefdinir. Each bottle of suspension contains 250 mg of reconstituted powder. The medication should be shaken well before use and any unused portion must be discarded 10 days after preparation. The suspension should be reconstituted with 43 mL of water to obtain 60 mL of medication. The National Drug Code (NDC) for this medication is 0093-4137-64.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
